Wataru Kudaka

1.0k total citations
48 papers, 451 citations indexed

About

Wataru Kudaka is a scholar working on Obstetrics and Gynecology, Surgery and Epidemiology. According to data from OpenAlex, Wataru Kudaka has authored 48 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Obstetrics and Gynecology, 16 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Wataru Kudaka's work include Endometrial and Cervical Cancer Treatments (32 papers), Cervical Cancer and HPV Research (13 papers) and Ovarian cancer diagnosis and treatment (11 papers). Wataru Kudaka is often cited by papers focused on Endometrial and Cervical Cancer Treatments (32 papers), Cervical Cancer and HPV Research (13 papers) and Ovarian cancer diagnosis and treatment (11 papers). Wataru Kudaka collaborates with scholars based in Japan, United States and Ukraine. Wataru Kudaka's co-authors include Yoichi Aoki, Yutaka Nagai, Takafumi Toita, Morihiko Inamine, Sadayuki Murayama, Tomoko Nakamoto, Takuro Ariga, Naoki Yoshimi, T. Oda and Yasumasa Kakinohana and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gynecologic Oncology.

In The Last Decade

Wataru Kudaka

43 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wataru Kudaka Japan	13	283	164	136	104	101	48	451
Hye Yon Cho South Korea	13	233 0.8×	100 0.6×	129 0.9×	153 1.5×	69 0.7×	41	446
Suwanit Therasakvichya Thailand	10	116 0.4×	108 0.7×	109 0.8×	76 0.7×	70 0.7×	25	365
Sinan Berkman Türkiye	11	193 0.7×	83 0.5×	101 0.7×	218 2.1×	66 0.7×	38	460
Lua Eiriksson Canada	11	132 0.5×	89 0.5×	102 0.8×	101 1.0×	84 0.8×	33	360
Eun Young Ki South Korea	12	138 0.5×	145 0.9×	171 1.3×	111 1.1×	122 1.2×	29	414
R. Kürzl Germany	10	152 0.5×	138 0.8×	86 0.6×	100 1.0×	91 0.9×	30	363
Benedetta Guani France	12	338 1.2×	231 1.4×	77 0.6×	281 2.7×	71 0.7×	40	494
Ceyhun Numanoğlu Türkiye	12	254 0.9×	63 0.4×	136 1.0×	272 2.6×	50 0.5×	35	462
Ioannis Biliatis United Kingdom	13	331 1.2×	139 0.8×	86 0.6×	268 2.6×	84 0.8×	29	519
Carla Merisio Italy	15	433 1.5×	151 0.9×	121 0.9×	373 3.6×	114 1.1×	42	642

Countries citing papers authored by Wataru Kudaka

Since Specialization

Citations

This map shows the geographic impact of Wataru Kudaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wataru Kudaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wataru Kudaka more than expected).

Fields of papers citing papers by Wataru Kudaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wataru Kudaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wataru Kudaka. The network helps show where Wataru Kudaka may publish in the future.

Co-authorship network of co-authors of Wataru Kudaka

This figure shows the co-authorship network connecting the top 25 collaborators of Wataru Kudaka. A scholar is included among the top collaborators of Wataru Kudaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wataru Kudaka. Wataru Kudaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nishio, Shin, Tadaaki Nishikawa, Masahiko Mori, et al.. (2025). Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial. Journal of Gynecologic Oncology. 36(4). e118–e118.

Nakamoto, Tomoko, et al.. (2022). Prognostic Factors of Cervical Adenocarcinoma With Positive Pelvic Lymph Node Metastases Without Preoperative Lymph Node Enlargement Treated With Radical Hysterectomy. Cancer Diagnosis & Prognosis. 3(1). 96–101.

Nakamoto, Tomoko, et al.. (2022). Comprehensive Genomic Profiling for Therapeutic Decision and Identification of Gene Mutation in Uterine Endometrial Dedifferentiated Carcinoma. SHILAP Revista de lepidopterología. 15(1). 46–55. 1 indexed citations

Kudaka, Wataru, et al.. (2022). Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy. Anticancer Research. 42(10). 4887–4893. 6 indexed citations

Nakamoto, Tomoko, et al.. (2022). Effects of Pegylated Liposomal Doxorubicin and CA125 Level Variability Analysis in Platinum-refractory/resistant Recurrent Ovarian Cancer. Anticancer Research. 42(6). 3017–3022.

Ishikawa, Mitsuya, Taro Shibata, Takashi Iwata, et al.. (2021). A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysis. Gynecologic Oncology. 162(2). 292–298. 10 indexed citations

Toita, Takafumi, Takuro Ariga, Wataru Kudaka, et al.. (2020). Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients. International Journal of Clinical Oncology. 25(11). 1977–1984. 10 indexed citations

Ariga, Takuro, Joichi Heianna, Tomoko Nakamoto, et al.. (2020). Long-term Outcomes of Cervical Adenocarcinoma Treated With Concurrent Chemoradiotherapy Using Paclitaxel and Cisplatin. In Vivo. 34(5). 2739–2743. 6 indexed citations

Nagai, Yutaka, Takafumi Toita, Takuro Ariga, et al.. (2020). A Phase II Study of Neoadjuvant Chemotherapy Followed by Extended Field Concurrent Chemoradiotherapy for Para-aortic Lymph Node Positive Cervical Cancer. Anticancer Research. 40(6). 3565–3570. 8 indexed citations

10.

Arakaki, Yoshitaka, et al.. (2019). Surgical site infection in patients with endometrial cancer undergoing open surgery. European Journal of Gynaecological Oncology. 40(4). 599–602. 2 indexed citations

11.

Kudaka, Wataru, et al.. (2017). Vesicovaginal/rectovaginal fistula formation and outcome of Stage IVA carcinoma of the cervix treated with radiotherapy. European Journal of Gynaecological Oncology. 38(6). 938–942. 1 indexed citations

12.

Kudaka, Wataru, Hirofumi Matsumoto, H Aoyama, et al.. (2017). Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer. International Journal of Clinical Oncology. 23(3). 532–538. 15 indexed citations

13.

Ishikawa, Mitsuya, Takahiro Kasamatsu, Hitoshi Tsuda, et al.. (2017). Prognostic factors and optimal therapy for stages I–II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study. Gynecologic Oncology. 148(1). 139–146. 47 indexed citations

14.

Kudaka, Wataru, Tomoko Nakamoto, Maho Tsubakimoto, et al.. (2016). Low-Grade Endometrial Stromal Sarcoma with Intravenous and Intracardiac Extension: A Multidisciplinary Approach. Case Reports in Obstetrics and Gynecology. 2016. 1–6. 7 indexed citations

15.

Inamine, Morihiko, et al.. (2016). Prognostic factors in patients with vulvar cancer treated with primary surgery: a single-center experience. SpringerPlus. 5(1). 125–125. 10 indexed citations

16.

Kudaka, Wataru, et al.. (2015). Ovarian preservation in young women with endometrial cancer of endometrioid histology. Acta Obstetricia Et Gynecologica Scandinavica. 94(4). 430–434. 15 indexed citations

17.

Watanabe, Yoh, Hiroyuki Nomura, Masayuki Futagami, et al.. (2014). Paclitaxel and Carboplatin in Patients With Completely or Optimally Resected Carcinosarcoma of the Uterus. International Journal of Gynecological Cancer. 25(1). 92–97. 16 indexed citations

18.

Hirakawa, Makoto, Yutaka Nagai, Takafumi Toita, et al.. (2011). High-risk group for locoregional recurrence in patients with stage IB-IIB squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.. PubMed. 31(4). 1437–41. 8 indexed citations

19.

Nagai, Yutaka, et al.. (2011). Metastatic placental site trophoblastic tumour successfully treated with hysterectomy and EMA/CO chemotherapy. Journal of Obstetrics and Gynaecology. 31(1). 99–101.

20.

Nagai, Yutaka, Tsuyoshi Asato, Makoto Hirakawa, et al.. (2010). Impact of human papillomavirus genotype on response to treatment and survival in patients receiving radiotherapy for squamous cell carcinoma of the cervix. Experimental and Therapeutic Medicine. 1(3). 525–530. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact